COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

PET imaging reveals long-term heart and lung damage from COVID-19
New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments.
HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection
Currently in development, the “Generation Gold Standard” platform utilizes inert whole viruses to combat more strains of common illnesses, such as COVID and the flu. It’s on track for FDA approval in 2029.
HHS sued over RFK’s $11B cuts to infectious disease control
The Department of Health and Human Services is refusing to allocate funds meant to support state and local healthcare initiatives, as the money stemmed from now-defunct COVID-19 control efforts. A coalition of municipalities is suing to lift the block.
Owner of home healthcare company gets 14 months for defrauding COVID programs
Nakita Cannady, 49, was also convicted of defrauding Cigna to the tune of $194,000, billing the insurer for patient care hours her providers never filled.
Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?
COVID-19 may help explain the increased rates of cardiac and noncardiac mortality among TAVR patients, but there are several other factors to consider as well. Researchers explored nearly 11 years of STS/ACC registry data to learn more.

Heart complication seen for the first time in a young patient after COVID-19 vaccination

Researchers detailed the case in Circulation: Cardiovascular Imaging.

FDA authorizes Pfizer COVID-19 booster for 12- to 15-year-olds

The administration also shortened the mandatory wait time to receive a third shot from six to five months after completing a second dose.

Israel will begin offering a fourth dose of COVID-19 vaccine

High risk patients such as people over 60, the immunocompromised and healthcare workers will soon be eligible for another shot.

FDA authorizes Pfizer’s COVID-19 pill

Paxlovid becomes the first treatment for the coronavirus taken in pill form, the federal agency announced.

COVID-19 vaccines tied to greater risk of myocarditis or myopericarditis—but specialists highlight the benefits of vaccination

The new analysis focused on nearly 5 million individuals who received either the Moderna or Pfizer/BioNTech vaccine.

Biden administration announces new actions to help hospitals keep up with omicron

The feds are making a large push to expand testing, setting up new sites across the U.S. and sending 500 million free kits to Americans beginning Jan. 1.

CDC now recommends Moderna, Pfizer/BioNTech COVID-19 vaccines over Johnson & Johnson’s due to risk of fatal blood clots

Johnson & Johnson’s vaccine has been associated with an elevated risk of thrombosis with thrombocytopenia syndrome.

Cardiologist interviewed by Joe Rogan claims U.S. withheld early COVID-19 treatments to promote fear, push support for vaccines

Peter A. McCullough, MD, has been no stranger to controversy during the ongoing pandemic.

COVID-19

PET imaging reveals long-term heart and lung damage from COVID-19

HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection

HHS sued over RFK’s $11B cuts to infectious disease control

Owner of home healthcare company gets 14 months for defrauding COVID programs

Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?